Skip to main content

Publications

Duke Surgery faculty and residents publish more than 500 peer-reviewed research articles each year, including many publications in high impact factor journals.

Search the list of publications below by faculty name or sort by division to learn more about our research endeavors.

Lin, Chao-Chieh, Nathaniel W. Mabe, Yi-Tzu Lin, Wen-Hsuan Yang, Xiaohu Tang, Lisa Hong, Tianai Sun, et al. “RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.” Cell Death Differ 27, no. 7 (July 2020): 2234–47. https://doi.org/10.1038/s41418-020-0499-y.

Full Text

Brown, Zachary D., Muath Bishawi, Jun-Neng Roan, Franklin Lee, Adam Nevo, Michael Watson, and Dawn E. Bowles. “The use of an inexpensive processing aid device (the Mouse PAD) to facilitate rodent tissue banking.” Biotechniques 69, no. 1 (July 2020): 364–68. https://doi.org/10.2144/btn-2019-0069.

Full Text

Tolbert, William D., Verna Van, Rebekah Sherburn, Marina Tuyishime, Fang Yan, Dung N. Nguyen, Sherry Stanfield-Oakley, et al. “Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial.” Mbio 11, no. 3 (June 30, 2020). https://doi.org/10.1128/mBio.00208-20.

Full Text

Schmitz, Robin, Zachary W. Fitch, He Xu, Ada Ghali, Aneesh K. Mehta, Antonio Guasch, and Allan D. Kirk. “Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up.” Am J Transplant, June 8, 2020. https://doi.org/10.1111/ajt.16121.

Full Text

Lewis, Phoebe E., Ethan C. Poteet, Dongliang Liu, Changyi Chen, Celia C. LaBranche, Sherry A. Stanfield-Oakley, David C. Montefiori, Guido Ferrari, and Qizhi Yao. “CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses.” Vaccines (Basel) 8, no. 2 (June 6, 2020). https://doi.org/10.3390/vaccines8020284.

Full Text

Kasturi, Sudhir Pai, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, Mathew Pham, Traci Legere, Zarpheen Jinnah Sher, Yevgeny Kovalenkov, et al. “3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates.” Science Immunology 5, no. 48 (June 2020). https://doi.org/10.1126/sciimmunol.abb1025.

Full Text

Lu, Yan, Ya-Si Huang, Chin-Ho Chen, Toshiyuki Akiyama, Susan L. Morris-Natschke, Yung-Yi Cheng, Ih-Sheng Chen, Sheng-Zehn Yang, Dao-Feng Chen, and Kuo-Hsiung Lee. “Anti-HIV tigliane diterpenoids from Reutealis trisperma.” Phytochemistry 174 (June 2020): 112360. https://doi.org/10.1016/j.phytochem.2020.112360.

Full Text

Chen, Alan Chen, Renhuan Xu, Tao Wang, Junping Wei, Xiao-Yi Yang, Cong-Xiao Liu, Gangjun Lei, Herbert Kim Lyerly, Teri Heiland, and Zachary Conrad Hartman. “HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression.” J Immunother Cancer 8, no. 1 (June 2020). https://doi.org/10.1136/jitc-2019-000258.

Full Text

Lévy, Yves, Christine Lacabaratz, Kim Ellefsen-Lavoie, Wolfgang Stöhr, Jean-Daniel Lelièvre, Pierre-Alexandre Bart, Odile Launay, et al. “Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.” Plos Pathog 16, no. 6 (June 2020): e1008522. https://doi.org/10.1371/journal.ppat.1008522.

Full Text

Sempowski, Gregory D., Kevin O. Saunders, Priyamvada Acharya, Kevin J. Wiehe, and Barton F. Haynes. “Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.” Cell 181, no. 7 (June 2020): 1458–63. https://doi.org/10.1016/j.cell.2020.05.041.

Full Text

Pages